NLRP3 and Sepsis: Other studies have demonstrated that exogenous NRG1 administration attenuates oxidative stress and inflammation by inhibiting the production of reactive oxygen species IL-1β and NLRP3 inflammasome (93), and supports cardiac repair, sepsis, traumatic spinal cord injury (50-57, 93-96).